Medtech Talk
Healthegy
Add to My Podcasts
Episodes
About
Reviews
Promote
ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology
27 minutes
Posted Aug 11, 2016 at 4:00 am.
0:00
27:34
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.
Previous
What Will Carl Zeiss Meditec’s New Ophthalmology Unit Look Like? We Ask Jim Mazzo.
Next
Where Are Series A Dollars Coming From? What Areas Are Ripe for M&A? You May Be Surprised
← See all 207 episodes of Medtech Talk